Autoimmune inflammatory myopathy after treatment with ipilimumab.
Hunter
Gary
G
Department of Neurology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Voll
Chris
C
Robinson
Christopher A
CA
D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use*; D015703:Antigens, CD / Q000276:immunology*; D001327:Autoimmune Diseases / Q000175:diagnosis / Q000209:etiology*; D060908:CTLA-4 Antigen; D005260:Female; D006801:Humans; D000074324:Ipilimumab; D008545:Melanoma / Q000188:drug therapy*; D008875:Middle Aged; D009220:Myositis / Q000139:chemically induced*
D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D060908:CTLA-4 Antigen; C556706:CTLA4 protein, human; D000074324:Ipilimumab